English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

“The right treatment for the patient at the right moment at the highest efficacy” this is the dogma for the future of medicine, in particular, for the paediatric population. By years children have been excluded by the pharmaceutical developmental process having no or very late access to innovative drugs; to date bringing advancement from the translational medicine to children presents additional obstacles and requires specific efforts. Early diagnosis, search for biomarkers to understand pathophysiology and test the efficacy and safety of new treatments are the major goals to realise personalised medicines.

Advanced healthcare for children and youth: application of targeted prevention, predictive diagnostics and personalised treatment approaches